BRIEF-Cytokinetics and Royalty Pharma announce $100 million transaction for Omecamtiv Mecarbil
February 02, 2017 at 08:04 AM EST
* Cytokinetics and Royalty Pharma announce $100 million transaction for Omecamtiv Mecarbil
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|